Prescription Required.
Is the active ingredient in medications used to manage type 2 diabetes.
Treatment of type 2 diabetes mellitus in adults, particularly when diet and exercise alone are insufficient to control blood sugar levels.
Q Repa 1mg Tab (Repaglinide) is a meglitinide, a type of oral hypoglycemic agent. It works by stimulating the release of insulin from the beta cells in the pancreas. This effect is dependent on the presence of glucose; repaglinide does not stimulate insulin release in the absence of glucose. It helps to lower blood glucose levels, primarily after meals.
Store at room temperature (below 25°C), away from moisture and direct sunlight. Keep out of reach of children.
Dosage is determined by your doctor based on your individual needs and response to treatment. It typically involves taking a tablet before each main meal.
Do not exceed the prescribed dose. Always follow your doctor's instructions carefully.
The dose may need to be adjusted based on blood glucose monitoring results.
Hypoglycemia (low blood sugar): This is the most common side effect and can cause symptoms like dizziness, sweating, trembling, and confusion.
Nausea
Vomiting
Diarrhea
Abdominal pain
Headache
Drowsiness
Weight gain
Alcohol can increase the risk of hypoglycemia. Limit alcohol intake while taking repaglinide and discuss with your doctor.
Hypoglycemia can impair judgment and coordination. Avoid driving or operating machinery if you experience symptoms of low blood sugar.
Repaglinide is generally not recommended during pregnancy or breastfeeding. Discuss with your doctor about alternative options.
Repaglinide is not usually prescribed for children.
Kidney impairment may affect how your body processes repaglinide. Your doctor will adjust your dose accordingly.
Liver impairment may affect how your body processes repaglinide. Your doctor will adjust your dose accordingly, and close monitoring might be necessary.
Consult your doctor or pharmacist for detailed information and specific references.
